Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement according to § 130a para. 8 SGB V for the active ingredient Hydroxycarbamide (excl. Dafo. FTA), ATC L01XX05 for the period 01.08.2026 - 31.07.2028 (plus extension option 1x12 months)
GKV-Spitzenverband · Germany
Create your free account to open it in qlows — full record, documents, and triage.
Already have an account? Log in · Free account · no card required
